Aniruddha Chatterjee is originally from Berhampore (West Bengal, India) where he completed his schooling. He moved to southern part of India and completed BSc (Osmania University, Hyderabad) and MSc degree (VIT University, Vellore) in Biotechnology with first class and distinction. Following this, Aniruddha came to the University of Otago in New Zealand in 2009, where he commenced his PhD and in his doctoral work, for the first time he mapped whole genome-scale DNA methylation patterns and variation in normal human neutrophil cells. Currently, he works in Dept. of Pathology at Otago and the main research interest of his lab lies in understanding driver epigenetic alterations in cancer metastasis and development of epigenetic biomarkers to predict patient response. Aniruddha already published 50 peer-reviewed articles and played a leading role in performing first reduced representation DNA methylation sequencing in human neutrophil, melanoma cancer cells and the model organism zebrafish. He also heavily published in the methodology development for DNA methylation and microRNA and gene expression analysis. Outside work, he enjoys dance/acting, sports, travelling and music. Aniruddha received several national and international awards for his work. In 2017, he was awarded one of the most prestigious fellowship in southern hemisphere, the Rutherford Discovery Fellowship from Royal Society of New Zealand. He is the founder of the Epigenetics User Group (EUG) in Otago and he substantially contributed in establishing a strong research programme in epigenetics and currently he is the head of the Epigenetics, Disease, and Phenotype Laboratory (EDP) at the University of Otago, New Zealand (URL: https://www.otago.ac.nz/chatterjee-lab/index.html)